PaulineFunchainMD

Oncology • Palo Alto, CA

Cancer Genetics/Cancer Risk Assessment, Melanoma

Medical Oncology/Cancer Genetics

Join to view full profile

Dr. Funchain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Funchain's full profile

Already have an account?

Office
300 Pasteur Dr
Palo Alto, CA 94304
Phone+1 650-723-4000

Education & Training

Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2009 - 2012
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 2006 - 2009
Ohio State University College of MedicineClass of 2006

Certifications & Licensure

CA State Medical License 2023 - 2025
OH State Medical License 2009 - 2025
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma Start of enrollment: 2018 Sep 21
Completed
Phase 3

Publications & Presentations

PubMed

642 citations
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.
Bryan J. Schneider, Jarushka Naidoo, Bianca Santomasso, Christina Lacchetti, Sherry Adkins
Journal of Clinical Oncology. 2021-11-01
153 citations
The Consequences of Growth of a Mutator Strain of Escherichia coli as Measured by Loss of Function Among Multiple Gene Targets and Loss of Fitness
Pauline Funchain, Annie Yeung, Jean Lee Stewart, Rose Lin, Malgorzata M. Slupska
Genetics. 2000-03-01
113 citations
Epigenetic Profiling in Chronic Lymphocytic Leukemia Reveals Novel Methylation Targets
Laura J. Rush, Aparna Raval, Pauline Funchain, Amy J. Johnson, Lisa L. Smith
Cancer Research. 2004-04-01

Abstracts/Posters

Biomarker Assessment of Venous Thromboembolism in Cancer Patients Receiving Checkpoint Blockade
Pauline Funchain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Multiplex germline testing in selected melanomas presenting to oncology clinic.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

Inherited Risk May Play a Larger Role in Melanoma Than Previously BelievedJune 20th, 2024
Inherited Genes Play a Larger Role in Melanoma Risk Than Previously BelievedMay 23rd, 2024
Here’s What Skin Cancer Looks like, Dermatologists Say — Eat This Not ThatApril 9th, 2022
Join now to see all

Other Languages

Thai